# Study to Evaluate the Safety and Effectiveness of the enVista® Beyond (EY) EDF Intraocular Lens in Subjects Undergoing Cataract Extraction

> **NCT06333015** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Bausch & Lomb Incorporated** · enrollment: 304 (actual)

## Conditions studied

- Cataract

## Interventions

- **DEVICE:** enVista Beyond EY (EDF) IOL
- **DEVICE:** enVista MX60E monofocal IOL

## Key facts

- **NCT ID:** NCT06333015
- **Lead sponsor:** Bausch & Lomb Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-08-07
- **Primary completion:** 2026-07
- **Final completion:** 2026-07
- **Target enrollment:** 304 (ACTUAL)
- **Last updated:** 2025-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06333015

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06333015, "Study to Evaluate the Safety and Effectiveness of the enVista® Beyond (EY) EDF Intraocular Lens in Subjects Undergoing Cataract Extraction". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06333015. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
